Protocol and Registration
This systematic review followed a published protocol[22] and was prospectively registered in PROSPERO (02 Dec 2020, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020222567). The review is reported in line with the 2020 PRISMA checklist (available in supplementary file 1)[23] facilitated by the PERSiST guidance.[24]
Eligibility Criteria
The eligibility criteria were pre-specified by the Population-Exposure-Outcome-Study (PEOS) design and are described below.
Population
The population of focus was adults aged 18 – 65 years old who had undergone a primary ACLR with no concomitant injuries. Studies were included where participants were <18 years but the mean age of the overall population was ≥18. Studies were included where participants had sustained a concomitant injury where results were separated.
Exposure
To be included, studies needed to identify at least one potential modifiable preoperative predictor variable and the relationship between the predictor(s) and RTPA. All estimates considered to determine the relationship between the predictive factor and outcome of interest were included (e.g., odds ratio and p-value). Predictive factors could be physical (e.g., quadriceps strength), psychosocial (e.g., anxiety) or demographic/clinical (e.g., graft type and time to surgery). We defined modifiable predictor variables as any factor that can be assessed and altered prior to surgery.
Outcome
The main outcome of interest was the success of RTPA. The identified preoperative risk factors needed to be linked to the outcome of interest. No time limit post-ACLR was defined for the reported outcome. If a study included multiple post-operative time-points, all were included. All measures of RTPA were included (e.g., participant reported [yes/no] or validated measures [Tegner, Marx scale], this list was, however, not exhaustive).
Study
Prospective, retrospective and cross-sectional study designs published in English with full texts available were included.
Search Strategy
A pre-defined and published search strategy was followed and completed in December 2020[22]. The search strategy included a combination of key words in four categories: (1) ACL, (2) preoperative, (3) risk factor and (4) RTPA. Terms were matched to Medical Subject Headings (MeSH) and combined using Boolean operators (e.g. Preoperative period OR Preop* OR Pre-op* OR Periop*). This search was carried out in six electronic databases in addition to screening the reference lists of included articles. This was updated in December 2021 to ensure no new studies were published during the write-up phase of this review.
Study Selection
Title and abstract screening was completed by one reviewer (HC). Two reviewers (HC and BS) independently screened full text articles for inclusion against the eligibility criteria. Agreement was discussed to reach consensus with discrepancies solved by the third reviewer (GL). Authors were contacted via the corresponding details if further information was required.
Data Extraction
Data extraction was completed by one reviewer (HC) in a form that was piloted prior to the review and described in the published protocol. Extracted data included study design, participant details (number, age, sex), preoperative predictors, outcome measures and time point of outcome assessment post-surgery.[22] The accuracy of data extraction was verified by a second reviewer (BS).
Risk of Bias Assessment
The Quality in Prognostic Studies (QUIPS) tool was used to assess for risk of bias for all included studies by two reviewers (HC and BS) independently. The QUIPS tool comprises of six domains to assess study participation, study attrition, prognostic factor measurement, outcome measurement, study confounding and statistical analysis and reporting.[25–27] A rating of low, moderate or high risk of bias is given for each domain to facilitate an overall risk of bias rating for each study. Disagreements between the reviewers were resolved through discussion.
GRADE
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was also used to rate each predictor variable. GRADE has previously been adapted for prognostic research[28] to consider two factors that may increase the quality (moderate or large effect size and exposure-response gradient) and six factors that may decrease the quality (phase of investigation, study limitations, inconsistency, indirectness, imprecision and publication bias). This was therefore considered alongside the original framework.[29,30]
The starting point of assessment for all studies was to determine the phase of investigation as advised by Huguet et al.[28] It was deemed all studies sought to identify associations between potential prognostic factors and the outcome of interest and so all started at a 'moderate' level of evidence. Publication bias was not assessed as funnel plot asymmetry is recommended to only be used when there are ten or more studies included.[31] Two reviewers independently rated each prognostic factor (HC and BS) and discrepancies were resolved through discussion.
Data Synthesis and Analysis
Clinical heterogeneity was assessed through visual examination of the data extraction table on details related to participant characteristics, risk factors, study design and processes in the included studies. Data were deemed to be heterogeneous due to the wide variety in study design, risk factors, reported outcome measures (e.g. Tegner and patient reported yes/no) and time to follow-up (e.g. 1 year, 2 years and 5-10 years) and so a narrative synthesis was completed.
Predictor variables were classified as physical, psychosocial, or demographic/clinical. For each variable, the number of studies it was investigated in and the number of studies showing a relationship to RTPA were determined. Predictor variables were classified as having a predictive, variable, or non-predictive relationship to RTPA based on a synthesis of these findings.